Synaptotagmin-7 phosphorylation mediates GLP-1-dependent potentiation of insulin secretion from beta-cells
10.2337/diabetes.50.11.2497 55
If injections have become a barrier (skipped doses, ongoing aversion, repeated logistical issues), an oral option may be worth discussing with your endocrinologist
Participants receiving higher trial doses, including 12 mg, reported side effects more frequently compared with some lower-dose groups
We are currently evaluating claims involving the following diagnoses: Severe Gastroparesis (Stomach Paralysis) Ileus (Bowel Obstruction) Intraoperative Pulmonary Aspiration (Choking on stomach contents during surgery) Other Serious Gastrointestinal Injuries requiring ER visits or hospitalization
L., Ott, V., Oster, H., & Hallschmid, M